SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Remedy Taking a hit why? -- Ignore unavailable to you. Want to Upgrade?

To: Shege Dambanza who wrote (421)1/5/1998 11:53:00 PM
From: John Ritter  Respond to of 763
 
Maybe, what concerned me was more the small size of the company and the nitch market, they may be something else, or another dowtick like with DATM (for example). The 'flats' can lead to other slops, best to follow this one for awhile, see where she goes, DATM looked good at 20, but it was a buy at 13, we shall see.



To: Shege Dambanza who wrote (421)1/7/1998 8:34:00 PM
From: Clam Clam  Read Replies (2) | Respond to of 763
 
Shege, that press release back at the end of October turned out to be what we suspected. It comes out now that there was significant sales management turnover at Remedy right after they report a back-end loaded quarter and sitting in front of what should be the biggest quotas of the year (Q4). It just didn't add up.

exchange2000.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News